Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 10/20 | 0.40 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL14672693 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL14672704 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL4592445 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL14735852 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL3257950 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL459208 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL14672707 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL19469979 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL4249292 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 | |
| Chloroform SCHEMBL1493337 | 1.00 | TSHR (0.42) | TSHRTHRBFDPSSMPD1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114752227-B | Sensitizing dye, sensitizing dye composition for photoelectric conversion, photoelectric conversion element using same, and dye sensitized solar cell | 保土谷化学工业株式会社 | 2023-09-01 | — | — | CN | disclosed |
| CN-114752227-A | Sensitizing dye, sensitizing dye composition for photoelectric conversion, photoelectric conversion element using same, and dye-sensitized solar cell | 保土谷化学工业株式会社 | 2022-07-15 | — | — | CN | disclosed |
| CN-110337466-B | Sensitizing dye, sensitizing dye composition for photoelectric conversion, photoelectric conversion element using same, and dye-sensitized solar cell | 保土谷化学工业株式会社 | 2022-03-08 | — | — | CN | disclosed |
| CN-110337466-A | Sensitizing dye, sensitizing dye composition for photoelectric conversion, photoelectric conversion element using same, and dye-sensitized solar cell | 保土谷化学工业株式会社 | 2019-10-15 | — | — | CN | disclosed |
| US-20190221749-A1 | CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | KYULUX, INC. (JP) | 2019-07-18 | — | — | US | disclosed |
| US-20120116073-A1 | P2X4 RECEPTOR ANTAGONIST | NIPPON CHEMIPHAR COL, LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| EP-1753839-B1 | POLYMER LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | SHOWA DENKO KK (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-20100256123-A1 | P2X4 RECEPTOR ANTAGONIST | NIPPON CHEMIPHAR CO., LTD. (JP) | 2010-10-07 | — | — | US | disclosed |
| CN-101541768-A | P2X4Receptor antagonists | NIPPON CHEMIPHAR CO (JP) | 2009-09-23 | — | — | CN | disclosed |
| EP-2058304-A1 | P2X4 RECEPTOR ANTAGONIST | Nippon Chemiphar Co., Ltd. (JP) | 2009-05-13 | — | — | EP | disclosed |
| US-7196081-B2 | Compounds with hydroxycarbonyl-halogenoalkyl side chains | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20050192449-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chains | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2005-09-01 | — | — | US | disclosed |
| US-6737417-B2 | AN ANTIESTROGENIC AGENT CONTAININING AROMATIC OR HETEROAROMATIC COMPOUNDS CONTAINING HYDROXYCARBONYL OR METAL SALT- HALOGENOALKYL SIDE CHAIN; USEFUL FOR TREATING BREAST CANCER | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2004-05-18 | — | — | US | disclosed |
| EP-1361205-A1 | Compounds with hydroxycarbonyl-halogenalkyl side chains | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030130347-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chains | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-07-10 | — | — | US | disclosed |
| US-20030114524-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chain | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1241158-A1 | COMPOUND HAVING HYDROXYCARBONYL-HALOGENOALKYL SIDE CHAIN | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-09-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256123-A1 | P2X4 RECEPTOR ANTAGONIST | P2RX1, P2RX3, P2RX4 | TSHR 482/4885THRB 591/4885FDPS 4562/4885 |
| US-20050192449-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chains | CYP19A1, HSD17B11, SHBG | TSHR 1465/4885THRB 1372/4885FDPS 2882/4885 |
| US-20120116073-A1 | P2X4 RECEPTOR ANTAGONIST | P2RX1, P2RX3, P2RX4 | TSHR 482/4885THRB 591/4885FDPS 4562/4885 |
| US-20190221749-A1 | CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT | SLC43A1, SLC7A5, SLC39A3 | TSHR 2938/4885THRB 3671/4885FDPS 4603/4885 |
| US-20030114524-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chain | HSD17B11, CYP19A1, SHBG | TSHR 2231/4885THRB 1257/4885FDPS 3181/4885 |
| US-20030130347-A1 | Compounds with hydroxycarbonyl-halogenoalkyl side chains | HSD17B11, CYP19A1, SHBG | TSHR 2277/4885THRB 1309/4885FDPS 3232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.